Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Editorial: Innovative Radiopharmaceuticals in Oncology and Neurology.
Barbet J, Arlicot N, Gaugler MH, Chérel M, Guilloteau D, Kraeber-Bodéré F. Barbet J, et al. Front Med (Lausanne). 2017 Jan 11;3:74. doi: 10.3389/fmed.2016.00074. eCollection 2016. Front Med (Lausanne). 2017. PMID: 28123998 Free PMC article. No abstract available.
Editorial: Nuclear Medicine in the Context of Personalized Medicine.
Barbet J, Bernaudin M, Payoux P, Cicone F, Gaugler MH, Kraeber-Bodéré F. Barbet J, et al. Front Med (Lausanne). 2020 Jun 9;7:252. doi: 10.3389/fmed.2020.00252. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32582736 Free PMC article. No abstract available.
Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model.
Fichou N, Gouard S, Maurel C, Barbet J, Ferrer L, Morgenstern A, Bruchertseifer F, Faivre-Chauvet A, Bigot-Corbel E, Davodeau F, Gaschet J, Chérel M. Fichou N, et al. Among authors: barbet j. Front Med (Lausanne). 2015 Nov 4;2:76. doi: 10.3389/fmed.2015.00076. eCollection 2015. Front Med (Lausanne). 2015. PMID: 26582128 Free PMC article.
Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients.
Bodet-Milin C, Ferrer L, Rauscher A, Masson D, Rbah-Vidal L, Faivre-Chauvet A, Cerato E, Rousseau C, Hureaux J, Couturier O, Salaün PY, Goldenberg DM, Sharkey RM, Kraeber-Bodéré F, Barbet J. Bodet-Milin C, et al. Among authors: barbet j. Front Med (Lausanne). 2015 Nov 27;2:84. doi: 10.3389/fmed.2015.00084. eCollection 2015. Front Med (Lausanne). 2015. PMID: 26640780 Free PMC article.
Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches.
Bodet-Milin C, Bailly C, Touchefeu Y, Frampas E, Bourgeois M, Rauscher A, Lacoeuille F, Drui D, Arlicot N, Goldenberg DM, Faivre-Chauvet A, Barbet J, Rousseau C, Kraeber-Bodéré F. Bodet-Milin C, et al. Among authors: barbet j. Front Med (Lausanne). 2019 Jun 4;6:124. doi: 10.3389/fmed.2019.00124. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31214593 Free PMC article. Review.
Cell Tracking in Cancer Immunotherapy.
Perrin J, Capitao M, Mougin-Degraef M, Guérard F, Faivre-Chauvet A, Rbah-Vidal L, Gaschet J, Guilloux Y, Kraeber-Bodéré F, Chérel M, Barbet J. Perrin J, et al. Among authors: barbet j. Front Med (Lausanne). 2020 Feb 14;7:34. doi: 10.3389/fmed.2020.00034. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32118018 Free PMC article. Review.
Improvement of radioimmunotherapy using pretargeting.
Frampas E, Rousseau C, Bodet-Milin C, Barbet J, Chatal JF, Kraeber-Bodéré F. Frampas E, et al. Among authors: barbet j. Front Oncol. 2013 Jun 20;3:159. doi: 10.3389/fonc.2013.00159. eCollection 2013. Front Oncol. 2013. PMID: 23802097 Free PMC article.
Tumor immunotargeting using innovative radionuclides.
Kraeber-Bodéré F, Rousseau C, Bodet-Milin C, Mathieu C, Guérard F, Frampas E, Carlier T, Chouin N, Haddad F, Chatal JF, Faivre-Chauvet A, Chérel M, Barbet J. Kraeber-Bodéré F, et al. Among authors: barbet j. Int J Mol Sci. 2015 Feb 11;16(2):3932-54. doi: 10.3390/ijms16023932. Int J Mol Sci. 2015. PMID: 25679452 Free PMC article. Review.
321 results